
Sensus Healthcare Inc
NASDAQ:SRTS

Intrinsic Value
The intrinsic value of one
SRTS
stock under the Base Case scenario is
9.06
USD.
Compared to the current market price of 4.32 USD,
Sensus Healthcare Inc
is
Undervalued by 52%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Sensus Healthcare Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Sensus Healthcare Inc
Balance Sheet Decomposition
Sensus Healthcare Inc
Current Assets | 54.2m |
Cash & Short-Term Investments | 19.1m |
Receivables | 18m |
Other Current Assets | 17.1m |
Non-Current Assets | 6m |
PP&E | 3.3m |
Other Non-Current Assets | 2.7m |
Free Cash Flow Analysis
Sensus Healthcare Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Sensus Healthcare Inc
Revenue
|
39.5m
USD
|
Cost of Revenue
|
-17.4m
USD
|
Gross Profit
|
22.1m
USD
|
Operating Expenses
|
-19.6m
USD
|
Operating Income
|
2.6m
USD
|
Other Expenses
|
-756k
USD
|
Net Income
|
1.8m
USD
|
SRTS Profitability Score
Profitability Due Diligence
Sensus Healthcare Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Score
Sensus Healthcare Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
SRTS Solvency Score
Solvency Due Diligence
Sensus Healthcare Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Score
Sensus Healthcare Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SRTS Price Targets Summary
Sensus Healthcare Inc
According to Wall Street analysts, the average 1-year price target for
SRTS
is 11.22 USD
with a low forecast of 10.1 USD and a high forecast of 13.65 USD.
Dividends
Current shareholder yield for SRTS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SRTS
stock under the Base Case scenario is
9.06
USD.
Compared to the current market price of 4.32 USD,
Sensus Healthcare Inc
is
Undervalued by 52%.